anandamide drug
Evidence from:
primary |
all sources
Related entities (24)
Mentioned in (28)
Papers in which this entity is mentioned.
- Shared genetic risk between eating disorder- and substance-use-related phenotypes: Evidence from genome-wide association studies. (2021)
- Prenatal drug exposure and neurodevelopmental programming of glucocorticoid signalling. (2020)
- ABHD4-dependent developmental anoikis safeguards the embryonic brain. (2020)
- The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development. (2018)
- An Update on Non-CB, Non-CB Cannabinoid Related G-Protein-Coupled Receptors. (2017)
- Lipids and Oxidative Stress Associated with Ethanol-Induced Neurological Damage. (2016)
- Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors. (2015)
- Endocannabinoids are conserved inhibitors of the Hedgehog pathway. (2015)
- Modulation of pilocarpine-induced seizures by cannabinoid receptor 1. (2014)
- Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies. (2014)
- Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity? (2014)
- Ethanol exposure induces neonatal neurodegeneration by enhancing CB1R Exon1 histone H4K8 acetylation and up-regulating CB1R function causing neurobehavioral abnormalities in adult mice. (2014)
- Neuronal substrates and functional consequences of prenatal cannabis exposure. (2014)
- Moving around the molecule: relationship between chemical structure and in vivo activity of synthetic cannabinoids. (2014)
- Baths salts, spice, and related designer drugs: the science behind the headlines. (2014)
- Adolescent chronic mild stress alters hippocampal CB1 receptor-mediated excitatory neurotransmission and plasticity. (2013)
- Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity. (2013)
- Cannabinoid receptor 1 signaling in embryo neurodevelopment. (2012)
- Receptor heteromerization expands the repertoire of cannabinoid signaling in rodent neurons. (2012)
- Soluble epoxide hydrolase inhibition, epoxygenated fatty acids and nociception. (2011)
- Pharmacological treatment of cannabis dependence. (2011)
- Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors. (2011)
- Cannabis and psychosis/schizophrenia: human studies. (2009)
- Repeated homotypic stress elevates 2-arachidonoylglycerol levels and enhances short-term endocannabinoid signaling at inhibitory synapses in basolateral amygdala. (2009)
- Interaction between two independent CNR1 variants increases risk for cocaine dependence in European Americans: a replication study in family-based sample and population-based sample. (2009)
- Acute ethanol suppresses glutamatergic neurotransmission through endocannabinoids in hippocampal neurons. (2008)
- Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. (1997)
- The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling. (1995)
Merged raw entities (5)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| anandamide | drug | 28 | 99 |
| endocannabinoid anandamide | drug | — | — |
| endogenous anandamide | drug | — | — |
| endogenous cannabinoid anandamide | drug | — | — |
| n-arachidonoylethanolamine | drug | — | — |